Tweet
<img alt="" height="1" width="1" />
Vivus' Qnexa improves sleep apnea in small trial
Reuters
LOS ANGELES, Jan 7 (Reuters) - A small, mid-stage trial of Qnexa, an experimental weight loss drug developed by Vivus Inc (VVUS.O), showed that drug reduced the incidence of sleep apnea events by 69 percent, the company said on Thursday. ...
Vivus Anti-Obesity Treatment Shown To Reduce Sleep ApneaWall Street Journal
Vivus says Qnexa helped treat sleep apnea in studyCNBC
VIVUS Announces Positive Results From Phase 2 Study of Qnexa in Obstructive ...PR Newswire (press release)
Today's Trucking News -MSN Money -PR Newswire (press release)
all 21 news articles »
More...